Browse by author
Lookup NU author(s): Professor Brian WalkerORCiD
This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).
© 2014 the American Physiological Society. To investigate the potential of therapies which reduce glucocorticoid action in patients with Type 2 diabetes we performed a randomized, double-blinded, placebo-controlled crossover study of acute glucocorticoid blockade, using the glucocorticoid receptor antagonist RU38486 (mifepristone) and cortisol biosynthesis inhibitor (metyrapone), in 14 men with Type 2 diabetes. Stable isotope dilution methodologies were used to measure the rates of appearance of glucose, glycerol, and free fatty acids (FFAs), including during a low-dose (10 mU·m 2·min 1) hyperinsulinemic clamp, and subgroup analysis was conducted in patients with high or low liver fat content measured by magnetic resonance spectroscopy (n 7/group). Glucocorticoid blockade lowered fasting glucose and insulin levels and improved insulin sensitivity of FFA and glycerol turnover and hepatic glucose production. Among this population with Type 2 diabetes high liver fat was associated with hyperinsulinemia, higher fasting glucose levels, peripheral and hepatic insulin resistance, and impaired suppression of FFA oxidation and FFA and glycerol turnover during hyperinsulinemia. Glucocorticoid blockade had similar effects in those with and without high liver fat. Longer term treatments targeting glucocorticoid action may be useful in Type 2 diabetes with and without fatty liver.
Author(s): Macfarlane DP, Raubenheimer PJ, Preston T, Gray CD, Bastin ME, Marshall I, Iredale JP, Andrew R, Walker BR
Publication type: Article
Publication status: Published
Journal: American Journal of Physiology - Gastrointestinal and Liver Physiology
Year: 2014
Volume: 307
Issue: 7
Pages: G760-G768
Print publication date: 01/10/2014
Online publication date: 01/10/2014
Acceptance date: 16/07/2014
Date deposited: 02/02/2018
ISSN (print): 0193-1857
ISSN (electronic): 1522-1547
Publisher: American Physiological Society
URL: https://doi.org/10.1152/ajpgi.00030.2014
DOI: 10.1152/ajpgi.00030.2014
PubMed id: 25104497
Altmetrics provided by Altmetric